A detailed history of Harbor Advisors LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Harbor Advisors LLC holds 2,000 shares of MRNA stock, worth $236,640. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,000
Previous 3,000 33.33%
Holding current value
$236,640
Previous $298,000 28.52%
% of portfolio
0.04%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$85.37 - $115.44 $85,370 - $115,440
-1,000 Reduced 33.33%
2,000 $213,000
Q4 2023

Feb 01, 2024

BUY
$69.51 - $104.43 $208,530 - $313,290
3,000 New
3,000 $298,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Harbor Advisors LLC Portfolio

Follow Harbor Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Advisors LLC with notifications on news.